相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-Term Metformin Usage and Cognitive Function among Older Adults with Diabetes
Tze Pin Ng et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Incretin-Modulated Beta Cell Energetics in Intact Islets of Langerhans
David J. Hodson et al.
MOLECULAR ENDOCRINOLOGY (2014)
Metformin-mode of action and clinical implications for diabetes and cancer
Ida Pernicova et al.
NATURE REVIEWS ENDOCRINOLOGY (2014)
LIXISENATIDE RESCUES SPATIAL MEMORY AND SYNAPTIC PLASTICITY FROM AMYLOID β PROTEIN-INDUCED IMPAIRMENTS IN RATS
H. -Y. Cai et al.
NEUROSCIENCE (2014)
Central glucagon-like peptide 1 receptor-induced anorexia requires glucose metabolism-mediated suppression of AMPK and is impaired by central fructose
Melissa A. Burmeister et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2013)
Crosstalk between diabetes and brain: Glucagon-like peptide-1 mimetics as a promising therapy against neurodegeneration
A. I. Duarte et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Mitochondrial Abnormalities in a Streptozotocin-Induced Rat Model of Sporadic Alzheimer's Disease
Sonia C. Correia et al.
Current Alzheimer Research (2013)
Advances in Pharmacologic Therapies for Type 2 Diabetes
Linde M. Morsink et al.
CURRENT ATHEROSCLEROSIS REPORTS (2013)
Increased Risk of Cognitive Impairment in Patients With Diabetes Is Associated With Metformin
Eileen M. Moore et al.
DIABETES CARE (2013)
Neuroprotective Effects of Liraglutide for Stroke Model of Rats
Kenichiro Sato et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Type 2 Diabetic and Alzheimer's Disease Mice Present Similar Behavioral, Cognitive, and Vascular Anomalies
Cristina Carvalho et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
DPP-4 inhibitors improve cognition and brain mitochondrial function of insulin-resistant rats
Hiranya Pintana et al.
JOURNAL OF ENDOCRINOLOGY (2013)
The role of FOXO1 in β-cell failure and type 2 diabetes mellitus
Tadahiro Kitamura
NATURE REVIEWS ENDOCRINOLOGY (2013)
Liraglutide protects against amyloid-β protein-induced impairment of spatial learning and memory in rats
Wei-Na Han et al.
NEUROBIOLOGY OF AGING (2013)
Insulin-induced recurrent hypoglycemia exacerbates diabetic brain mitochondrial dysfunction and oxidative imbalance
Susana Cardoso et al.
NEUROBIOLOGY OF DISEASE (2013)
The Diabetes Drug Liraglutide Ameliorates Aberrant Insulin Receptor Localisation and Signalling in Parallel with Decreasing Both Amyloid-β Plaque and Glial Pathology in a Mouse Model of Alzheimer's Disease
Caitriona M. Long-Smith et al.
NEUROMOLECULAR MEDICINE (2013)
Pharmacologic agents for type 2 diabetes therapy and regulation of adipogenesis
A. Cignarelli et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2013)
Investigational anti-hyperglycemic agents: the future of type 2 diabetes therapy?
Sachin K. Majumdar et al.
ENDOCRINE (2013)
Amelioration of neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer's disease by exendin-4
Song Chen et al.
AGE (2012)
Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment A Pilot Clinical Trial
Suzanne Craft et al.
ARCHIVES OF NEUROLOGY (2012)
Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis
Kerry Hunter et al.
BMC NEUROSCIENCE (2012)
Insulin signaling, glucose metabolism and mitochondria: Major players in Alzheimer's disease and diabetes interrelation
Sonia C. Correia et al.
BRAIN RESEARCH (2012)
Metabolic Alterations Induced by Sucrose Intake and Alzheimer's Disease Promote Similar Brain Mitochondrial Abnormalities
Cristina Carvalho et al.
DIABETES (2012)
Metformin-Induced Hepatotoxicity
Francisco Miralles-Linares et al.
DIABETES CARE (2012)
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Silvio E. Inzucchi et al.
DIABETES CARE (2012)
Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis
C. F. Deacon et al.
DIABETES OBESITY & METABOLISM (2012)
GLP-1 based therapies: differential effects on fasting and postprandial glucose
M. S. Fineman et al.
DIABETES OBESITY & METABOLISM (2012)
Dipeptidylpeptidase-IV, a key enzyme for the degradation of incretins and neuropeptides: activity and expression in the liver of lean and obese rats
E. Tarantola et al.
EUROPEAN JOURNAL OF HISTOCHEMISTRY (2012)
An update on type 2 diabetes, vascular dementia and Alzheimer's disease
L. G. Exalto et al.
EXPERIMENTAL GERONTOLOGY (2012)
Glucagon-like peptide-1 decreases intracerebral glucose content by activating hexokinase and changing glucose clearance during hyperglycemia
Michael Gejl et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)
Roles of AMP-activated Protein Kinase in Alzheimer's Disease
Zhiyou Cai et al.
NEUROMOLECULAR MEDICINE (2012)
Metformin attenuates Alzheimer's disease-like neuropathology in obese, leptin-resistant mice
Jiejie Li et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2012)
Insulin resistance in the nervous system
Bhumsoo Kim et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)
Understanding the benefit of metformin use in cancer treatment
Ryan J. O. Dowling et al.
BMC MEDICINE (2011)
Clarifying the Role of Incretin-Based Therapies in the Treatment of Type 2 Diabetes Mellitus
R. Keith Campbell
CLINICAL THERAPEUTICS (2011)
Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: a comparative review
C. F. Deacon
DIABETES OBESITY & METABOLISM (2011)
Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials
C. Lamanna et al.
DIABETES OBESITY & METABOLISM (2011)
Glucagon-like Peptide-1 Analogues for Type 2 Diabetes Mellitus Current and Emerging Agents
Baptist Gallwitz
DRUGS (2011)
The glucagon-like peptide 1 receptor agonist exendin-4 improves reference memory performance and decreases immobility in the forced swim test
Ruben Isacson et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Incidence of Dementia is Increased in Type 2 Diabetes and Reduced by the Use of Sulfonylureas and Metformin
Chih-Cheng Hsu et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Nuclear translocation of AMPK-α1 potentiates striatal neurodegeneration in Huntington's disease
Tz-Chuen Ju et al.
JOURNAL OF CELL BIOLOGY (2011)
The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's Disease
Paula L. McClean et al.
JOURNAL OF NEUROSCIENCE (2011)
Novel GLP-1 Mimetics Developed To Treat Type 2 Diabetes Promote Progenitor Cell Proliferation in the Brain
A. Hamilton et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2011)
Management of type 2 diabetes: new and future developments in treatment
Abd A. Tahrani et al.
LANCET (2011)
Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes
Amit Gupta et al.
NEUROPHARMACOLOGY (2011)
Impact of STZ-Induced Hyperglycemia and Insulin-Induced Hypoglycemia in Plasma Amino Acids and Cortical Synaptosomal Neurotransmitters
Susana Cardoso et al.
SYNAPSE (2011)
Mechanisms of metformin action on glucose transport and metabolism in human adipocytes
Jean Grisouard et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Cortical and hippocampal mitochondria bioenergetics and oxidative status during hyperglycemia and/or insulin-induced hypoglycemia
Susana Cardoso et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2010)
Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology
Paula I. Moreira et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2010)
Regulation of mitochondrial biogenesis
Francois R. Jornayvaz et al.
ESSAYS IN BIOCHEMISTRY: MITOCHONDRIAL FUNCTION (2010)
Long-term inhibition of dipeptidyl peptidase-4 in Alzheimer's prone mice
Michele D'Amico et al.
EXPERIMENTAL GERONTOLOGY (2010)
Effects of AMP-activated protein kinase in cerebral ischemia
Jun Li et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2010)
How does diabetes accelerate Alzheimer disease pathology?
Catrina Sims-Robinson et al.
NATURE REVIEWS NEUROLOGY (2010)
Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling
Eva Kickstein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Pharmacological profile of lixisenatide: A new GLP-1 receptor agonist for the treatment of type 2 diabetes
Ulrich Werner et al.
REGULATORY PEPTIDES (2010)
A review of exenatide as adjunctive therapy in patients with type 2 diabetes
Gisela Robles
Drug Design Development and Therapy (2010)
Sulfonylurea pharmacogenomics in Type 2 diabetes: the influence of drug target and diabetes risk polymorphisms
Christina L. Aquilante
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2010)
(Pre)diabetes, brain aging, and cognition
Jarbas S. Roriz-Filho et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
Safety, tolerability, pharmacodynamics and pharmacokinetics of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in healthy subjects
M. A. Bush et al.
DIABETES OBESITY & METABOLISM (2009)
Type II Diabetes in Mild Cognitive Impairment and Alzheimer's Disease: Results from a Prospective Population-Based Study in Germany
Pablo Toro et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
An Integrative View of the Role of Oxidative Stress, Mitochondria and Insulin in Alzheimer's Disease
Paula I. Moreira et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
AMPK in the brain: its roles in energy balance and neuroprotection
Gabriele V. Ronnett et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Glucagon-Like Peptide-1 Induced Signaling and Insulin Secretion Do Not Drive Fuel and Energy Metabolism in Primary Rodent Pancreatic β-Cells
Marie-Line Peyot et al.
PLOS ONE (2009)
GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism
Yazhou Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription
Yaomin Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Insulin Resistance and Alzheimer's Disease: Molecular Links & Clinical Implications
Karen F. Neumann et al.
CURRENT ALZHEIMER RESEARCH (2008)
Glycemic control in diabetes: A tale of three studies
Zachary T. Bloomgarden
DIABETES CARE (2008)
More choices than ever before - Emerging therapies for type 2 diabetes
R. Keith Campbell et al.
DIABETES EDUCATOR (2008)
The role of advanced glycation end products in progression and complications of diabetes
Su-Yen Goh et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Cognition and diabetes: a lifespan perspective
Geert Jan Biessels et al.
LANCET NEUROLOGY (2008)
Metformin protects the brain against the oxidative imbalance promoted by type 2 diabetes
Sonia Correia et al.
MEDICINAL CHEMISTRY (2008)
PPARγ agonists as therapeutics for the treatment of Alzheimer's disease
Gary Landreth et al.
NEUROTHERAPEUTICS (2008)
10-year follow-up of intensive glucose control in type 2 diabetes
Rury R. Holman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Metformin promotes isolated rat liver mitochondria impairment
Cristina Carvalho et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2008)
Common pathological processes in Alzheimer disease and type 2 diabetes: A review
Lin Li et al.
BRAIN RESEARCH REVIEWS (2007)
Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes -: Importance of postprandial glycemia to achieve target HbA1c levels
Hans J. Woerle et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2007)
Biology of incretins: GLP-1 and GIP
Laurie L. Baggio et al.
GASTROENTEROLOGY (2007)
Thiazolidinediones improve β-cell function in type 2 diabetic patients
Amalia Gastaldelli et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Exendin-4 potently decreases ghrelin levels in fasting rats
Diego Perez-Tilve et al.
DIABETES (2007)
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
Daniel J. Drucker et al.
LANCET (2006)
Diabetes mellitus and dementia
F. Pasquier et al.
DIABETES & METABOLISM (2006)
Insulin restores metabolic function in cultured cortical neurons subjected to oxidative stress
Ana I. Duarte et al.
DIABETES (2006)
Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy - A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes
David M. Nathan et al.
DIABETES CARE (2006)
Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice
Ward A. Pedersen et al.
EXPERIMENTAL NEUROLOGY (2006)
The impact of diabetes on cognition: What can be learned from rodent models?
GJ Biessels et al.
NEUROBIOLOGY OF AGING (2005)
Peripheral hyperinsulinemia promotes tau phosphorylation in vivo
S Freude et al.
DIABETES (2005)
Insulin resistance syndrome and Alzheimer's disease: Age- and obesity-related effects on memory, amyloid, and inflammation
S Craft
NEUROBIOLOGY OF AGING (2005)
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial
JA Dormandy et al.
LANCET (2005)
Insulin neuroprotection against oxidative stress in cortical neurons - Involvement of uric acid and glutathione antioxidant defenses
AI Duarte et al.
FREE RADICAL BIOLOGY AND MEDICINE (2005)
β-cell preservation:: a potential role for thiazolidinediones to improve clinical care in Type 2 diabetes
LA Leiter
DIABETIC MEDICINE (2005)
Glucagon-related peptide 1 (GLP-1): Hormone and neurotransmitter
PJ Larsen et al.
REGULATORY PEPTIDES (2005)
Pharmacological inhibition of AMP-activated protein kinase provides neuroprotection in stroke
LD McCullough et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Pyruvate administered after severe hypoglycemia reduces neuronal death and cognitive impairment
SW Suh et al.
DIABETES (2005)
Type 2 diabetes: principles of pathogenesis and therapy
M Stumvoll et al.
LANCET (2005)
Glycemic management of type 2 diabetes: An emerging strategy with oral agents, insulins, and combinations
MC Riddle
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2005)
Potential role of oral thiazolidinedione therapy in preserving beta-cell function in type 2 diabetes mellitus
H Walter et al.
DRUGS (2005)
The ascent of mouse: Advances in modelling human depression and anxiety
JF Cryan et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease
L Ho et al.
FASEB JOURNAL (2004)
Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes
LL Nielsen et al.
REGULATORY PEPTIDES (2004)
Increased risk of type 2 diabetes in Alzheimer disease
J Janson et al.
DIABETES (2004)
Metformin inhibits mitochondrial permeability transition and cell death:: a pharmacological in vitro study
B Guigas et al.
BIOCHEMICAL JOURNAL (2004)
A recombinant human glucagon-like peptide (GLP)-1-albumin protein (Albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis
LL Baggio et al.
DIABETES (2004)
Oxidative stress affects synaptosomal γ-aminobutyric acid and glutantate transport in diabetic rats -: The role of insulin
AI Duarte et al.
DIABETES (2004)
Type 2 diabetes in the young: The evolving epidemic - The International Diabetes Federation Consensus Workshop
G Alberti et al.
DIABETES CARE (2004)
Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030 - Response to Rathman and Giani
SH Wild et al.
DIABETES CARE (2004)
Glucagon-like peptide-1 receptor is involved in learning and neuroprotection
MJ During et al.
NATURE MEDICINE (2003)
Influence of rosiglitazone treatment on β-cell function in type 2 diabetes:: Evidence of an increased ability of glucose to entrain high-frequency insulin pulsatility
CB Juhl et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Insulin affects synaptosomal GABA and glutamate transport under oxidative stress conditions
AI Duarte et al.
BRAIN RESEARCH (2003)
GSK-3α regulates production of Alzheimer's disease amyloid-β peptides
CJ Phiel et al.
NATURE (2003)
Glucagon-like peptide-1 mobilizes intracellular Ca2+ and stimulates mitochondrial ATP synthesis in pancreatic MIN6 β-cells
T Tsuboi et al.
BIOCHEMICAL JOURNAL (2003)
Hippocampal neuronal apoptosis in type 1 diabetes
ZG Li et al.
BRAIN RESEARCH (2002)
Ageing and diabetes: implications for brain function
GJ Biessels et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Oral antihyperglycemic therapy for type 2 diabetes - Scientific review
SE Inzucchi
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
A novel neutrotrophic property of glucagon-like peptide 1: A promoter of nerve growth factor-mediated differentiation in PC12 cells
T Perry et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Role of insulin and insulin receptor in learning and memory
WQ Zhao et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2001)
Initial sequencing and analysis of the human genome
ES Lander et al.
NATURE (2001)
Insulin receptors and insulin action in the brain: review and clinical implications
RJ Schulingkamp et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2000)
Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain
MR Owen et al.
BIOCHEMICAL JOURNAL (2000)
Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26
D Marguet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I
MY El-Mir et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
